ATHE
ATHE clinical trials: ALTERITY THERAPEUTICS LTD
Every trial on ClinicalTrials.gov where ALTERITY THERAPEUTICS LTD is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 9
- Trials linked
- 9
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
ATHE on the catalyst calendar · ATHE registry changes
- Primary completion Jul 2029Sponsor estimatePhase 2NCT07729852Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in FranceAlterity Therapeutics · Multiple System AtrophyEnrolling by invitationATHELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredNo phase registeredNCT07531433Post-Trial Access to ATH434 for Patients With Multiple System AtrophyAlterity Therapeutics · Multiple System AtrophyAvailableATHELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 26, 2025ActualPhase 2NCT05864365A Biomarker Study of ATH434 in Participants With MSAAlterity Therapeutics · Multiple System AtrophyCompletedATHELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 28, 2024ActualPhase 2NCT05109091Study of ATH434 in Participants with Multiple System AtrophyAlterity Therapeutics · Multiple System AtrophyCompletedATHELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2013ActualPhase 2NCT01590888Effect of PBT2 in Patients With Early to Mid Stage Huntington DiseasePrana Biotechnology Limited · Huntington DiseaseCompletedATHELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2014ActualPhase 1NCT02109497Phase 1 Study to Determine the Effects of PBT2 on the Pharmacokinetic Profile of CaffeinePrana Biotechnology Limited · Healthy VolunteersCompletedATHELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2014ActualPhase 1NCT02249728Absorption, Metabolism and Excretion Study of [14C]PBT2 and Absolute Bioavailability of PBT2Prana Biotechnology Limited · Healthy VolunteersCompletedATHELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2014ActualPhase 1NCT02107313Phase 1 Study to Determine the Effects of Food on the Pharmacokinetic Profile of PBT2Prana Biotechnology Limited · Healthy VolunteersCompletedATHELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2007ActualPhase 2NCT00471211Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's DiseasePrana Biotechnology Limited · Alzheimer's DiseaseCompletedATHELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 9 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner